Nattokinase bleeding risk: aspirin, blood thinners, and surgery

By Marcus Renshaw ·

Two case reports tell you almost everything about nattokinase safety, and they point in opposite directions. In one, an older woman took over-the-counter nattokinase for an irregular heartbeat, on nothing else that thinned her blood, and died of internal bleeding. In the other, a man stopped his warfarin and ran nattokinase in its place after a heart valve replacement, threw a clot onto the mechanical valve, and needed the valve replaced again. Too much thinning killed one. Too little thinning, from trusting a supplement to do a drug’s job, nearly killed the other.

Nattokinase is a functional blood thinner. It carries a real bleeding risk on its own and a larger one stacked with aspirin, warfarin, or a DOAC, with documented case reports including fatal internal bleeding and aspirin-combined brain hemorrhage. Standard guidance is to avoid it with any blood thinner and to stop it about two weeks before surgery.

Is nattokinase a blood thinner?

Functionally, yes, even though it is sold as a supplement rather than a drug. Nattokinase is a fibrinolytic enzyme: it breaks down fibrin, the protein mesh that holds a clot together, which is the same job the mechanism section of the nattokinase and arterial plaque piece describes in detail. The reason that matters for safety is that an enzyme dissolving fibrin cannot tell a dangerous clot from the clot you need after a cut, a tooth extraction, or a surgical incision.

Its main action, per the Memorial Sloan Kettering monograph, is inactivating plasminogen activator inhibitor, which frees up tissue plasminogen activator to convert plasminogen into plasmin, the body’s own clot dissolver. It also cleaves fibrin directly. Two routes to the same effect: less clot. That is useful in a stack built to offset clotting risk, and it is exactly the property that turns dangerous in the wrong combination.

What are the real bleeding case reports?

The evidence here is not a randomized trial, it is a set of published case reports, and they are worth knowing by name because the abstract “may increase bleeding risk” language hides how the harm actually happens. This matters because the controlled trials look clean: a meta-analysis of six randomized trials in 546 people reported no notable adverse events from nattokinase, and even it added that case reports of bleeding have emerged and that anyone taking it should be monitored on their clotting parameters. Trials enroll people without the risk factors that every one of these case reports shares, which is exactly why the reports, not the trial averages, are where the real safety information lives.

  • Fatal internal bleeding, nattokinase alone. Memorial Sloan Kettering records an elderly woman who took over-the-counter nattokinase for a rapid irregular heartbeat, on no other blood thinner, and died of internal bleeding. This is the one that breaks the “it is only risky if you combine it” reassurance. Alone, in the wrong person, it was enough.
  • Cerebellar hemorrhage with aspirin. A 2008 case report in Internal Medicine describes a patient on daily aspirin for stroke prevention who took nattokinase 400 mg a day for just seven days and had a bleed into the cerebellum. Brain imaging showed pre-existing cerebral microbleeds. Seven days was enough to tip an already fragile vascular bed.
  • Clot from using it as a substitute. The valve case above: a patient self-replaced warfarin with nattokinase after an aortic valve replacement, formed a thrombus on the mechanical valve, and needed a second replacement. Nattokinase is not strong enough or reliable enough to stand in for a prescribed anticoagulant, and treating it as one is its own distinct danger.

There is also a genuinely extreme one, an arm amputation after someone injected an oral enzyme supplement containing serrapeptase and nattokinase to self-treat a different condition. That is a lesson about never injecting oral supplements more than about nattokinase specifically, but it belongs on the list of what people actually do.

Can you take nattokinase with aspirin, warfarin, or a DOAC?

The general answer is no, not without a clinician managing it, and the detail differs by drug.

With aspirin or another antiplatelet, the effects add. Memorial Sloan Kettering notes nattokinase may increase the risk of intracerebral hemorrhage taken with aspirin, which is precisely the cerebellar bleed above. Daily low-dose aspirin is common enough in this audience that this is the interaction most people will actually meet.

With a DOAC like apixaban or rivaroxaban, or any other anticoagulant, the same logic holds: you are adding a second agent that pushes toward bleeding, on top of one already dosed to a therapeutic effect.

Warfarin is the strange one, because it interacts in two opposite directions at once. Nattokinase the enzyme adds bleeding risk. But natto the food, and some supplements made from it, are rich in vitamin K, because the bacteria that ferment the soybeans keep producing it, and vitamin K is exactly what warfarin works by blocking. So a nattokinase product can simultaneously push bleeding risk up through fibrinolysis and push warfarin’s effect down through vitamin K, making the INR unstable in a way that is hard to predict or dose around. Memorial Sloan Kettering also notes nattokinase is a heparin-binding protein that interferes with heparin’s action. None of that is manageable by guessing.

Do you have to stop nattokinase before surgery?

Yes. The standard supplement guidance, and the sensible reading of the mechanism, is to stop nattokinase about two weeks before any scheduled surgery or dental procedure, and to tell the surgeon and anesthetist you were taking it even if you stopped.

Two weeks is not arbitrary. It is meant to clear the enzyme and let normal clotting recover before anyone deliberately cuts you, which is the moment you most need the clotting nattokinase spends its whole mechanism undoing. The same caution covers unplanned procedures indirectly: it is one more reason your full supplement list, nattokinase included, should be somewhere a clinician can see it in an emergency rather than in your memory alone. This is the same discipline that makes the subtraction test for supplements worth running, knowing what each item does and when it has to come out.

Who should avoid nattokinase entirely?

Some situations are not “manage it carefully,” they are “do not take it.” Memorial Sloan Kettering and the case literature converge on a clear list. Avoid nattokinase if you:

  • Take any anticoagulant, antiplatelet, or fibrinolytic drug, including daily aspirin
  • Have a coagulation or bleeding disorder
  • Have a history of stroke or known cerebral microbleeds. This includes ischemic stroke, not only bleeding stroke: the aspirin case report above was an ischemic-stroke patient, because that group is usually on antiplatelet drugs and often has fragile small vessels
  • Have an active peptic ulcer or another active bleeding source
  • Have a history of deep vein thrombosis, since nattokinase could theoretically dislodge an existing clot and send it somewhere worse
  • Are pregnant or breastfeeding, where the safety data does not exist
  • Are allergic to natto, since severe allergic reactions are on record

If none of those apply and you still want the fibrinolytic effect, the risk is lower, but “lower” is not “absent,” as the woman who died on nattokinase alone shows.

How a self-experimenter should actually handle it

Here the clinical guidance is the floor, not the whole answer, because the people reading this are the ones most likely to be running nattokinase deliberately rather than being warned off it by a doctor.

I keep nattokinase in my own stack for a narrow reason, to add a fibrinolytic layer against the clotting risk that a few of the compounds I run push the other way. The flip side of choosing to take a functional blood thinner is that I have to treat it like one. That means it comes out roughly two weeks before any procedure, it never shares a day with aspirin or anything else antiplatelet, and it is written down where the interaction is visible rather than sitting quietly in a pill organizer next to a fish oil that pulls the same direction. High-dose omega-3 is the interaction people in this crowd forget, because it does not feel like a drug.

The honest overlay is this. Nattokinase is a rare supplement with a real drug-like mechanism, the same reason it earns a spot in the middle tier of the supplement evidence stack rather than the bin, and it is also what makes “it is natural, so it is safe” a genuinely dangerous sentence here. The two failure modes are symmetric and both are in the case reports: take too much thinning by stacking it, or trust it to replace a drug it cannot replace. The way you stay out of both is boring. One job written down, the full interacting list beside it, a hard stop before any procedure, and a clinician who knows you take it. That is the entire safety protocol, and it is the reason the supplement journal in the Operating System bundle asks for an interaction note beside each item instead of just a name and a dose, so an enzyme that thins your blood is never sitting invisibly two rows above an aspirin.

If you already take anything that thins your blood, the move is not to start nattokinase carefully, it is to not start it without the person who manages that drug signing off first. If you take nothing else that touches clotting, write down its one job, note the two-week surgery stop, and tell your clinician before the first capsule, not after.

FAQ

Is nattokinase a blood thinner?

Functionally yes, though it is sold as a supplement. It is a fibrinolytic enzyme that breaks down fibrin, the protein scaffold of a clot, and it boosts the body’s own clot-dissolving pathway by freeing up tissue plasminogen activator. That is a genuine drug-like antithrombotic action, which is why it carries drug-like bleeding risks rather than being harmless because it comes from food.

Can I take nattokinase with aspirin?

Not without medical guidance. Their effects add, and Memorial Sloan Kettering notes nattokinase may increase the risk of intracerebral hemorrhage when taken with aspirin. A published case report describes a bleed into the cerebellum in a patient who combined daily aspirin with nattokinase for only seven days. Daily low-dose aspirin plus nattokinase is a combination to avoid.

Can I take nattokinase with warfarin?

No, and it is especially unpredictable. Nattokinase adds bleeding risk through fibrinolysis, while the vitamin K in natto-derived products can work against warfarin and destabilize the INR in the opposite direction. Nattokinase also binds heparin and interferes with its action. Do not combine it with warfarin or any anticoagulant without the prescriber managing it directly.

How long before surgery should I stop nattokinase?

About two weeks before any scheduled surgery or dental procedure, to let the enzyme clear and normal clotting recover before the incision. Tell your surgeon and anesthetist you were taking it even after you have stopped, and keep it on the medication list they see rather than relying on memory.

Is nattokinase safe to take on its own?

At the doses studied it has a mostly clean record in trials, but “mostly” is not “always.” Memorial Sloan Kettering records a fatal internal bleed in an older adult who took over-the-counter nattokinase alone for an irregular heartbeat. The risk is much higher when it is combined with other blood thinners, but it is not zero when taken by itself.

Who should not take nattokinase?

Anyone on an anticoagulant, antiplatelet, or aspirin, anyone with a bleeding or coagulation disorder, a history of stroke (ischemic as well as hemorrhagic) or cerebral microbleeds, an active peptic ulcer, or a history of deep vein thrombosis, plus pregnant or breastfeeding people and anyone allergic to natto. For these groups the guidance is to avoid it, not to dose it carefully.

Can nattokinase replace my prescribed blood thinner?

No, and trying is dangerous. A case report describes a patient who self-substituted nattokinase for warfarin after a heart valve replacement, formed a clot on the mechanical valve, and needed a second surgery. Nattokinase is neither strong enough nor consistent enough to do the job of a prescribed anticoagulant.

Sources